Cargando…
Can reducing planning safety margins broaden the inclusion criteria for lung stereotactic ablative body radiotherapy?
INTRODUCTION: Stereotactic ablative body radiotherapy (SABR) is currently indicated for inoperable, early‐stage non‐small cell lung carcinoma (NSCLC). Advancements in image‐guidance technology continue to improve treatment precision and enable reductions in planning safety margins. We investigated t...
Autores principales: | Ghandourh, Wsam, Batumalai, Vikneswary, Boxer, Miriam, Holloway, Lois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424332/ https://www.ncbi.nlm.nih.gov/pubmed/33934559 http://dx.doi.org/10.1002/jmrs.469 |
Ejemplares similares
-
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
por: Ghandourh, Wsam, et al.
Publicado: (2022) -
Imaging dose in breast radiotherapy: does breast size affect the dose to the organs at risk and the risk of secondary cancer to the contralateral breast?
por: Batumalai, Vikneswary, et al.
Publicado: (2015) -
Comparison of setup accuracy of three different image assessment methods for tangential breast radiotherapy
por: Batumalai, Vikneswary, et al.
Publicado: (2016) -
Comparison of Oncentra® Brachy IPSA and graphical optimisation techniques: a case study of HDR brachytherapy head and neck and prostate plans
por: Jameson, Michael G, et al.
Publicado: (2015) -
Palliative care in cancer: managing patients’ expectations
por: Ghandourh, Wsam A.
Publicado: (2016)